.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

RAXAR Drug Profile

« Back to Dashboard
Raxar is a drug marketed by Otsuka and is included in one NDA.

The generic ingredient in RAXAR is grepafloxacin hydrochloride. Additional details are available on the grepafloxacin hydrochloride profile page.

Summary for Tradename: RAXAR

Patents:0
Applicants:1
NDAs:1

Clinical Trials for: RAXAR

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Otsuka
RAXAR
grepafloxacin hydrochloride
TABLET;ORAL020695-001Nov 6, 1997DISCNNo<disabled><disabled>
Otsuka
RAXAR
grepafloxacin hydrochloride
TABLET;ORAL020695-002May 14, 1998DISCNNo<disabled><disabled>
Otsuka
RAXAR
grepafloxacin hydrochloride
TABLET;ORAL020695-003May 14, 1998DISCNNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: RAXAR

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Otsuka
RAXAR
grepafloxacin hydrochloride
TABLET;ORAL020695-001Nov 6, 19975,563,138<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc